01 Increasing Preference for Personalized Multi-dose Medication Packaging The growing burden of chronic diseases and polypharmacy is encouraging pharmacies to adopt personalized multi dose medication packaging for better medication management. This transition organizes multiple prescriptions into clearly labeled dose packs based on the patient's schedule, improving convenience and reducing medication errors. As a result, healthcare providers achieve better treatment adherence and operational efficiency.
02 Increasing Use of Paper-based and Recyclable Adherence Packaging Solutions Environmental sustainability goals are encouraging manufacturers to develop paper based and recyclable adherence packaging solutions. This transition reduces dependence on conventional plastics while maintaining the safety, durability, and labeling requirements needed for pharmaceutical packaging. As a result, pharmacies and healthcare providers can support sustainability initiatives without compromising medication protection.
01 The adherence packaging market forecasts continued investment activity driven by the rising focus on medication adherence, increasing prevalence of chronic diseases, and expanding adoption of pharmacy automation solutions. Investors are focusing on companies developing advanced adherence packaging systems, smart medication packaging technologies, and automated dispensing solutions that improve patient compliance, reduce medication errors, and enhance pharmacy workflow efficiency.In January 2026, BrightInsight announced a strategic investment round of USD 13 Million. The capital will support the digital health and adherence solutions platform in accelerating the development of its AI-enabled medication persistence and compliance tracking solutions. Backed by key institutional investors including Eclipse, General Catalyst, Insight Partners, Mayo Clinic, and New Leaf Venture Partners, the funding will also facilitate the global scalability of high-impact patient support applications across multiple chronic disease ecosystems.
01 The adherence packaging market is sensitive to supply chain disruptions due to its reliance on pharmaceutical-grade plastics, paperboard, aluminum foils, adhesives, and specialized packaging machinery sourced through global supply networks. Raw material shortages, transportation delays, and fluctuations in packaging material prices have affected production schedules, procurement costs, and delivery timelines for manufacturers and healthcare providers worldwide. These disruptions have accelerated supplier diversification, regional manufacturing expansion, and inventory optimization, strengthening the resilience of the global adherence packaging ecosystem. The market is experiencing an S-shaped recovery, with gradual stabilization followed by accelerated adoption driven by expanding pharmacy automation, growing medication adherence programs, and sustained demand from retail pharmacies, hospitals, and long-term care facilities.
01 Increasing Need to Reduce Medication Waste and Preference for Home-based Chronic Disease Management Drives Market The increasing need to reduce medication waste is driving demand for adherence packaging solutions. In June 2026, the US Centers for Medicare & Medicaid Services (CMS) updated its Medicare Part B discarded drug reporting and refund program, reinforcing efforts to reduce wasted medicines and improve drug utilization. Adherence packaging helps organize medicines, reducing unused doses and dispensing errors. This strengthens demand for unit dose and multi-dose packaging solutions.Home-based chronic disease management is creating demand for adherence packaging solutions. Patients with diabetes, cardiovascular diseases, and hypertension often require multiple daily medications, making organized packaging essential for treatment adherence. Adherence packaging simplifies medication schedules and reduces caregiver burden. This is encouraging pharmacies to expand home medication management services. For example, community pharmacies provide multi dose blister packs for elderly patients receiving long-term therapy.
01 High Costs of Installation & Maintenance and Complex Prescription Management and Workflow Integration Restrains Market Expansion The high cost of automated adherence packaging systems limits adoption among independent pharmacies, small healthcare providers, and long-term care facilities. Initial investment in packaging equipment, software integration, and ongoing maintenance increases the total cost of implementation. These financial barriers delay purchasing decisions and reduce penetration in cost sensitive healthcare markets, restraining overall market growth. Frequent prescription changes and the need to synchronize multiple medications make adherence packaging more complex for pharmacies. Additional labor, verification processes, and integration with pharmacy management systems increase operational complexity. This reduces adoption among pharmacies with limited staffing and technical capabilities.
01 Specialty Pharmacy Services and Value-based Healthcare Programs Offers Growth Opportunities to Market Players The growing use of specialty pharmacies for complex therapies creates new opportunities for adherence packaging providers. Patients receiving oncology, autoimmune, and rare disease medications benefit from organized packaging that improves dosing accuracy and treatment compliance. This creates opportunities for packaging manufacturers and pharmacy service providers to develop customized adherence solutions. Companies such as Omnicell are supporting specialty pharmacies with medication adherence and dispensing technologies.The shift toward value-based healthcare creates opportunities for adherence packaging providers to support better patient outcomes and lower healthcare costs. Healthcare systems, insurers, and pharmacies are seeking solutions that improve medication adherence and reduce avoidable hospital readmissions. This creates opportunities for manufacturers to develop packaging solutions aligned with outcome-based care models.
01 Limited Reimbursement for Adherence Packaging Services and Delayed Patient Acceptance Challenges Market Growth Limited reimbursement policies for adherence packaging services remain a key challenge, as many pharmacies receive little or no additional compensation for providing these value-added services. This reduces the financial incentive to offer adherence packaging, particularly in cost-sensitive healthcare systems, slowing market penetration. The challenge is more evident among independent pharmacies with limited operating margins.Patient acceptance remains a challenge, as some individuals prefer original manufacturer packaging or frequently change prescriptions, reducing the suitability of prepacked medication formats. This can lead to wasted packaged doses and lower utilization of adherence packaging services, affecting market growth. Independent community pharmacies often avoid enrolling patients with frequently changing medication regimens because repeated repackaging increases operational costs and product waste.
July 2026 Jones Healthcare Group announced a partnership with Venalink to showcase integrated community pharmacy and medication adherence solutions at the FIP World Congress 2026 in Montreal, strengthening pharmacy workflow and patient care solutions.
January 2026 Jones Healthcare Group launched the Adherence in Practice education initiative, a pharmacist-led training program reviewed by the Canadian Pharmacists Association to strengthen medication adherence services and pharmacy best practices.